EP1565129B1 - Expandable stents - Google Patents
Expandable stents Download PDFInfo
- Publication number
- EP1565129B1 EP1565129B1 EP03812435A EP03812435A EP1565129B1 EP 1565129 B1 EP1565129 B1 EP 1565129B1 EP 03812435 A EP03812435 A EP 03812435A EP 03812435 A EP03812435 A EP 03812435A EP 1565129 B1 EP1565129 B1 EP 1565129B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- medical device
- crimped
- stent
- diameter
- intraluminal medical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- WYTGDNHDOZPMIW-RCBQFDQVSA-N alstonine Natural products C1=CC2=C3C=CC=CC3=NC2=C2N1C[C@H]1[C@H](C)OC=C(C(=O)OC)[C@H]1C2 WYTGDNHDOZPMIW-RCBQFDQVSA-N 0.000 claims abstract description 19
- 229910052751 metal Inorganic materials 0.000 claims description 10
- 239000002184 metal Substances 0.000 claims description 10
- 229910001220 stainless steel Inorganic materials 0.000 claims description 3
- 239000010935 stainless steel Substances 0.000 claims description 3
- 239000004033 plastic Substances 0.000 claims description 2
- 229920003023 plastic Polymers 0.000 claims description 2
- 239000002131 composite material Substances 0.000 claims 1
- 239000000463 material Substances 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 238000002788 crimping Methods 0.000 description 5
- 238000002513 implantation Methods 0.000 description 5
- 150000002739 metals Chemical class 0.000 description 4
- 210000005166 vasculature Anatomy 0.000 description 4
- 229910045601 alloy Inorganic materials 0.000 description 3
- 239000000956 alloy Substances 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 229910000510 noble metal Inorganic materials 0.000 description 3
- 238000005096 rolling process Methods 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 238000003466 welding Methods 0.000 description 3
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 238000005452 bending Methods 0.000 description 2
- 238000005530 etching Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 239000012781 shape memory material Substances 0.000 description 2
- 229910052723 transition metal Inorganic materials 0.000 description 2
- 150000003624 transition metals Chemical class 0.000 description 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 229910000684 Cobalt-chrome Inorganic materials 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- WAIPAZQMEIHHTJ-UHFFFAOYSA-N [Cr].[Co] Chemical compound [Cr].[Co] WAIPAZQMEIHHTJ-UHFFFAOYSA-N 0.000 description 1
- MTHLBYMFGWSRME-UHFFFAOYSA-N [Cr].[Co].[Mo] Chemical compound [Cr].[Co].[Mo] MTHLBYMFGWSRME-UHFFFAOYSA-N 0.000 description 1
- HZEWFHLRYVTOIW-UHFFFAOYSA-N [Ti].[Ni] Chemical compound [Ti].[Ni] HZEWFHLRYVTOIW-UHFFFAOYSA-N 0.000 description 1
- -1 and so forth Substances 0.000 description 1
- 210000000013 bile duct Anatomy 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000003037 cerebral aqueduct Anatomy 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 239000010952 cobalt-chrome Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052741 iridium Inorganic materials 0.000 description 1
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 1
- 238000003698 laser cutting Methods 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 229910001000 nickel titanium Inorganic materials 0.000 description 1
- 210000003101 oviduct Anatomy 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 208000037803 restenosis Diseases 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 229910001256 stainless steel alloy Inorganic materials 0.000 description 1
- 229910052715 tantalum Inorganic materials 0.000 description 1
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- 210000003708 urethra Anatomy 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 210000002229 urogenital system Anatomy 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/91525—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other within the whole structure different bands showing different meander characteristics, e.g. frequency or amplitude
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/91533—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other characterised by the phase between adjacent bands
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/9155—Adjacent bands being connected to each other
- A61F2002/91558—Adjacent bands being connected to each other connected peak to peak
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/9155—Adjacent bands being connected to each other
- A61F2002/91575—Adjacent bands being connected to each other connected peak to trough
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0028—Shapes in the form of latin or greek characters
- A61F2230/0054—V-shaped
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0039—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in diameter
Definitions
- the present invention relates to endoprosthesis devices adapted for implantation into a body lumen such as a blood vessel to maintain the patency thereof.
- Stents are typically cylindrical or tubular radially expandable prostheses introduced via a catheter assembly into a lumen of a body vessel in a configuration having a generally reduced diameter, i.e. in a crimped or unexpanded state, and are then expanded to the diameter of the vessel.
- stents support or reinforce sections of vessel walls, for example a blood vessel, which have collapsed, are partially occluded, blocked, weakened, or dilated, and maintain them in an open unobstructed state.
- Stents are advantageous because they can reduce the likelihood of restenosis, and because the patency of the blood vessel is maintained immediately after the intravascular treatment.
- Stents are available in self-expanding and in mechanically expandable versions which employ a dilatation balloon for expansion. Both versions are well known and widely available in a variety of designs and configurations, and are made from a variety of materials including plastics and metals with metals being more typically used. Hybrid stents which have self-expanding and mechanically expandable characteristics are also known.
- a self-expanding stent may be positioned at the distal end of a catheter around a core lumen.
- Self-expanding stents are typically held in an unexpanded state during delivery using a variety of methods including sheaths or sleeves which cover all or a portion of the stent.
- sheaths or sleeves which cover all or a portion of the stent.
- Another method includes mounting a mechanically expandable stent on an expandable member, such as a dilatation balloon provided on the distal end of an intravascular catheter, advancing the catheter through a patient's vasculature to the desired location within the patient's body lumen, and inflating the balloon on the catheter to expand the stent into a permanent expanded condition.
- an expandable member such as a dilatation balloon provided on the distal end of an intravascular catheter
- advancing the catheter through a patient's vasculature to the desired location within the patient's body lumen
- inflating the balloon includes the use of inflation fluid.
- the expandable member is then deflated and the catheter removed from the body lumen, leaving the stent in the vessel to hold the vessel open.
- the advancement of the stent through a patient's vasculature can involve traversing sharp bends and other obstacles which may require the stent to be highly flexible and trackable.
- WO 02/091958 Al discloses a stent having first and second helical segments.
- the first helical segments are comprised of a plurality of first expandable elements and the second helical segments are comprised of a plurality of second helical elements.
- the expandable elements are joined to each other by a plurality of struts.
- the geometry is designed to provide an improved crimping of the stent.
- the technical problem of the invention is to provide an intraluminal medical device having a crimped state in which the intraluminal medical device is securely crimped on a delivery device.
- the intraluminal medical device has a pre-crimped diameter and a crimped diameter and is constructed and arranged such that the cylindrical shaped segments are crimped from the pre-crimped diameter to the crimped diameter and at least some of the end portions project inward.
- the inward projecting portions provide an improved retention on the balloon for delivery and deployment within the vasculature of a patient, while maintaining radial strength in the expanded configuration.
- the present invention provides a tubular, flexible, expandable intraluminal device generally referred to as a stent which has improved retention on the surface of a dilatation member, while maintaining radial strength in an expanded condition to maintain the patency of a body lumen such as an artery when implanted therein.
- the present invention relates to an intraluminal medical device having a flowpath therethrough.
- the device includes a plurality of substantially cylindrical serpentine shaped segments which define a generally tubular body, each serpentine segment having a plurality of interconnected struts interconnected by alternating first and second end portions, the segments which are adjacent one another connected one to the other.
- the medical device has a pre-crimped diameter and crimped diameter and is constructed and arranged such that as the cylindrical shaped segments are crimped from the pre-crimped diameter to the crimped diameter at least some of the end portions project into the delivery device. The projection of the end portions inwardly provides for improved securement to the delivery device prior to deployment at the desired location in the patient.
- the interconnected struts may be parallel or non-parallel.
- the end portions are substantially elliptical and the struts are substantially parallel forming substantially u-shaped members.
- the serpentine segments may be connected by connecting members of any configuration including curved, bent, linear, curvilinear, straight and so forth.
- the connecting members are straight.
- the present invention further relates to the intraluminal medical devices in combination with a catheter assembly which may further include an inflation member.
- the radially expandable stents of the present invention are designed for relative flexibility along the longitudinal axis of the stent to facilitate delivery through tortuous body lumens, but exhibit radial strength in an expanded state to maintain the patency of a body lumen such as an artery when implanted therein.
- the radially expandable stents of the present invention may have a first pre-crimped or manufactured diameter, a second crimped diameter, and a third expanded diameter wherein the third diameter desirably exceeds the first diameter.
- the present invention is directed to mechanically expandable stents formed with a pattern as described below, such pattern which is adapted for radial expansion from a first unexpanded or pre-crimped diameter to a second crimped diameter, and then to a third expanded diameter which approximates the inner diameter of the body lumen into which the stent is intended for implantation.
- the first pre-crimped diameter and third expanded diameter may or may not be similar.
- the stents also have a second diameter referred to generally herein as the crimped diameter.
- the stents of the present invention desirably have a first unexpanded or pre-crimped diameter which is significantly larger than the second crimped diameter.
- the pre-crimped diameter may be substantially the same as the tubing size from which the stent is cut. Thus, the pre-crimped diameter may also be referred to as the diameter of the tubing as manufactured.
- One method of expanding a mechanically expandable stent is through the use of an inflation member, such as a dilatation balloon.
- the stents may be further designed so as to have flexible portions which deform during bending and portions which provide improved radiopacity and radial strength which remain largely undeformed during bending.
- Fig. 1 shows a fragmentary flat view of one embodiment of an unexpanded stent according to the present invention exhibiting a plurality of adjacent segments 19, each of which is formed in an undulating flexible pattern of non-parallel struts 16.
- the struts may also be parallel. Pairs of struts are interconnected at alternating end portions 18a and 18b. As seen in Fig. 1 , the interconnecting end portions 18b of one segment are positioned opposite interconnecting end portions 18a of adjacent segments.
- the end portions shown are generally elliptical resulting in substantially U-shaped members formed by adjacent non-parallel struts. However, such end portions may be rounded, squared, pointed, and so forth. Any configuration of the end portions is acceptable providing that it results in a serpentine or undulating pattern.
- the stents of the present invention in general, may be described as tubular, radially expandable structures which include a plurality of cylindrical shaped open segments 19 aligned on a common longitudinal axis to define a generally tubular stent body.
- Each segment 19 may be defined by a member formed in an undulating flexible pattern of interconnected struts 16 with pairs thereof having alternating interconnecting end portions 18a, 18b to define the periphery of the expandable stent segment 19.
- the connected end portions 18a, 18b of paired struts 16 in each segment 19, before the stent is expanded, are optionally positioned substantially opposite to connected end portions 18a, 18b of paired struts 16 in adjacent segments 19 and are 180° out of phase with one another. In other embodiments, they may be in phase with one another or may have any other phase relationship.
- the segments 19 are interconnected by a plurality of interconnecting elements 20 extending from some of the connected end portions 18a, 18b on one segment 19 to some of the connected end portions 18a, 18b on adjacent segments 19.
- the connecting elements 20 extend angularly from connecting end portion 18a, 18b of one segment to connecting end portion 18a, 18b of an adjacent segment 19, not to an opposite connecting end portion 18a, 18b on an adjacent segment 19, whereby upon expansion of the stent 10 the adjacent segments 19 are displaced relative to each other about the periphery of the stent body to accommodate flexing of the stent 10 within paired struts 16 without interference between adjacent segments 19.
- the connectors in this particular embodiment are angular, the connectors may be straight, curvilinear, curved and so forth including s-shaped connectors, u-shaped connectors, v-shaped connectors, and so forth.
- the present invention is not intended to be limited to any particular type of connector and flexing may occur in the connectors, in the segment or both.
- the struts 16 and substantially elliptical end portions 18 form what may be referred to as a substantially U-shaped member shown in its pre-crimped state in Fig. 2 .
- the shape of the member will also vary and the present invention is not intended to be limited to any particular shaped end portion.
- the U-shaped member of Fig. 2 for example, is shown in its crimped state in Fig. 3 .
- the end portions 18 are shown projecting inwardly according to the present invention. Without being bound by theory, the result of the projection of the end portions inwardly during crimping provides enhanced securement of the stent to an inflation member on a catheter delivery device for example, and also may result in improved tracking of the device through the vasculature.
- the U-shaped member is further shown in an expanded state in Fig. 4 .
- the ends 19 are shown having little projection either inwardly or outwardly in the expanded state.
- the struts 16 of the intraluminal devices of the present invention have a strut width W which is not less than the strut thickness T shown in Figs. 2-4 .
- Fig. 5a illustrates generally at 10, a tubular, expandable stent of the present invention in its pre-crimped state.
- the diameter D1 of the stent in its pre-crimped state is taken at the proximal end of the stent and is noted as section 5b and is shown in Fig. 5b .
- the diameter of the stent in the pre-crimped state is substantially equal to the diameter of the tubing from which the stent is cut and may typically be in the range of about 0.04" (about 1.0 mm) to as high as about 0.4" (about 10 mm) or higher.
- the range of tubing size employed may vary depending on the intended use of the stent.
- Fig. 5c shows the stent of Fig. 5a in a crimped state.
- the stent in its crimped stated has a diameter D2.
- the stent is typically crimped to a diameter of about 0.025" (about 0.6 mm) to about 0.08" (about 2 mm), and more typically about 0.04" (about 1 mm) to about 0.05" (about 1.3 nun). Again, this size may be dictated by the intended use of the stent.
- the diameter D2 of the stent in the crimped state is shown in Fig. 5d .
- the diameter D1 of a stent in the pre-crimped state is similar to the diameter D2 of the stent in the crimped state in contrast to the present invention in which the diameter D1 of the stent in the pre-crimped state is significantly larger than the diameter D2 of the stent in the crimped state.
- Fig. 6a and 6b expanded views, illustrate an embodiment of the invention in which the stent is crimped from a pre-crimped diameter D1 to a crimped diameter D2.
- the pre-crimped diameter D1 is approximately four times that of the crimped diameter D2.
- a stent In an expanded state, a stent may range from about 2 mm to about 30 mm (about 0.08" to about 1.2").
- Fig. 7a shows a partial flat view of an alternative embodiment of a stent of the present invention in a pre-crimped state in which connectors 20, rather than being angular as shown in one embodiment above, are curved.
- the curvature of such connectors 20 may be varied.
- Connectors 20 are also shown between every adjacent end portion 18a, 18b between strut pairs 16. In the embodiment shown in Fig. 1 , for example, there are fewer connectors 20 between pairs of struts 16 with one connector 20 for every three pairs of struts 16.
- the strut pairs shown as being substantially parallel, are joined by elliptical end portions 18a, 18b as shown in the embodiment in Fig. 1 forming substantially u-shaped members.
- Fig. 7b illustrates the same stent as shown in Fig. 7a but in the tubular form.
- the stent may be formed by etching the pattern in a flat sheet and then rolling the sheet and sealing the edges together such as by welding in the case of a metal, or the stent pattern may be cut from a hollow tubular member.
- the stent may be formed from multiple sheets or multiple tubular members, as well as from multiple materials. As used herein, the term “multiple" shall be used to refer to two or more.
- Fig. 7c illustrates the same stent as shown in Figs. 7a and 7b in a crimped state.
- the end portions 18a, 18b of the u-shaped members project inwardly as shown in Fig. 7c .
- the diameter of the stent in a pre-crimped state is significantly larger than the diameter of the stent in the crimped state.
- Figs. 7b and 7c are not shown dimensionally accurate to one another.
- Fig. 7d shows a partial flat view of the stent in an expanded state.
- the end portions 18a, 18b of the u-shaped members do not project outwardly to any significant extent.
- Fig. 8a shows a partial flat view of an alternative embodiment of a stent of the present invention in a pre-crimped state in which connectors 20 are straight.
- Fig. 8b shows a three dimensional view of the stent of Fig. 8a in its tubular form.
- a first serpentine portion 12 eight peaks and eight troughs also referred to herein as end portions 18a, 18b per serpentine portion.
- a second serpentine portion 14 has twelve peaks and twelve troughs per serpentine portion also referred to herein as end portions 18c, 18d. Every third trough has a connector 20 extending therefrom.
- the ratio of end portions in the first serpentine band to end portions in the second serpentine band is thus 2:3.
- End portions 18a, 18b are elliptical and form U-shaped members between adjacent struts 16a of the first serpentine portions 12. Struts 16a are longer than struts 16b of the second serpentine portions 14 which are also connected by elliptical shaped end portions 18c, 18d.
- the stent may be formed by laser cutting a tube of stainless steel, or any other suitable stent material, and polished to smooth and round the edge surfaces.
- a pattern may also be cut from a single flat sheet of metal such as stainless steel, and then rolling the sheet and sealing the edges together such as by welding in the case of a metal, or the stent pattern may be cut from a hollow tubular member.
- the stent may be formed from more than one flat sheet or from one tubular member. The stent may be formed using multiple materials as well.
- Fig. 8c illustrates the same stent as shown in Figs. 8a and 8b in a crimped state. At least some of the end portions, 18a, 18b, 18c, 18d of the u-shaped members project inwardly as shown in Fig. 8c .
- the stent has first serpentine portions 12 which have struts 16a longer than struts 16b of second serpentine portions 14. The end portions 18a, 18b of first serpentine portions 12 are shown projecting inwardly.
- the end portions 18c, 18d of second serpentine portions 14 are shown in this embodiment as not projecting inwardly. However, in an alternate embodiment, end portions 18c, 18d of second serpentine portions 14 could also project inwardly.
- the diameter of the stent shown in Fig. 8a-8c in a pre-crimped state is larger than the diameter of the stent in the crimped state. It is important to note that the stents, and thus the diameters, are not drawn to scale. The diameter should be reduced by a factor of at least about 2 from the pre-crimped state to the crimped state.
- Figs. 8b and 8c are not shown dimensionally accurate to one another and thus are not representative of the relative diameters of the stent as shown in Fig. 8b to that same stent in crimped form shown in Fig. 8c .
- Fig. 10 shows the same stent as in Fig. 8c in its crimped state and mounted on a dilatation member 40.
- the stents of the present invention may be manufactured from any materials known in the art for use in forming such members, and suitably the tubular members may be made of a biocompatible material. Examples include, but are not limited to, the shape memory materials, noble metals, transition metals, any alloys of the shape memory materials, noble metals, transition metals, polymeric materials, and so forth.
- the stent may be manufactured of stainless steel alloys which include, but are not limited to, Special Chemistry of type 316L SS per ASTM F138-92 or ASTM F139-92 grade 2 and Special Chemistry of type 316L per ASTM F138-92 or ASTM F139-92 and so forth.
- metals suitable for formation of the inventive stents of the present invention include, but are not limited to the more radiopaque metals including the noble metals gold and platinum, and tantalum; iridium, palladium, tungsten, titanium, chromium, cobalt, molybdenum, nickel, silver, copper, zinc, and so forth, and alloys thereof.
- alloys useful for manufacture of the inventive stents herein include, but are not limited to, nickel-titanium, cobalt-chromium, cobalt-chromium-molybdenum, and so forth.
- the stent may be formed according to any method known in the art including etching a pattern and then rolling the sheet and sealing the edges together such as by welding, for example, or the stent may be cut from a hollow tube. If a flat metal sheet is employed, the etched pattern is then rolled into a tube and the tube is optionally welded or the like.
- stents of the present invention in combination with the inflation members may be further mounted on the distal end of a stent delivery catheter which is then passed through the body lumen to the site of implantation.
- the stent is mounted on the balloon catheter by crimping it onto the catheter employing methods known in the art.
- Fig. 9 illustrates a stent 10 of the present invention shown crimped to a dilatation member, in this embodiment, a catheter balloon 40 of a delivery catheter shown generally at 50.
- catheter delivery device shown in Fig. 10 is intended for illustrative purposes only.
- Catheter delivery devices useful for delivery of a medical device of the type described herein are well known to those of ordinary skill in the art and as such any suitable delivery catheter may be employed herein.
- the stent and the inflation member are typically compressed or crimped onto the catheter structure for delivery to the implantation site where the inflation member is inflated typically with an inflation fluid thus expanding the stent.
- Crimping devices are well known in the art and any suitable crimping device may be employed.
- the inflation member is then deflated and the catheter assembly removed from the body lumen leaving the stent behind.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Physics & Mathematics (AREA)
- Vascular Medicine (AREA)
- Optics & Photonics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Prostheses (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
- The present invention relates to endoprosthesis devices adapted for implantation into a body lumen such as a blood vessel to maintain the patency thereof.
- Intraluminal medical devices, for example, stents, are employed in a number of medical procedures and their structure and function are well known. Stents are typically cylindrical or tubular radially expandable prostheses introduced via a catheter assembly into a lumen of a body vessel in a configuration having a generally reduced diameter, i.e. in a crimped or unexpanded state, and are then expanded to the diameter of the vessel. In their expanded state, stents support or reinforce sections of vessel walls, for example a blood vessel, which have collapsed, are partially occluded, blocked, weakened, or dilated, and maintain them in an open unobstructed state. They have also been implanted in the urinary tract, in bile ducts, in the alimentary tract, in the tracheobronchial tree, in cerebral aqueducts, in the genitourinary system, in the prostatic urethra, in fallopian tubes, as well as other regions of the body. Stents are advantageous because they can reduce the likelihood of restenosis, and because the patency of the blood vessel is maintained immediately after the intravascular treatment.
- Stents are available in self-expanding and in mechanically expandable versions which employ a dilatation balloon for expansion. Both versions are well known and widely available in a variety of designs and configurations, and are made from a variety of materials including plastics and metals with metals being more typically used. Hybrid stents which have self-expanding and mechanically expandable characteristics are also known.
- Various methods are employed for delivery and implantation of a stent. For instance, a self-expanding stent may be positioned at the distal end of a catheter around a core lumen. Self-expanding stents are typically held in an unexpanded state during delivery using a variety of methods including sheaths or sleeves which cover all or a portion of the stent. When the stent is in its desired location of the targeted vessel the sheath or sleeve is retracted to expose the stent which then self-expands upon retraction.
- Another method includes mounting a mechanically expandable stent on an expandable member, such as a dilatation balloon provided on the distal end of an intravascular catheter, advancing the catheter through a patient's vasculature to the desired location within the patient's body lumen, and inflating the balloon on the catheter to expand the stent into a permanent expanded condition. One method of inflating the balloon includes the use of inflation fluid. The expandable member is then deflated and the catheter removed from the body lumen, leaving the stent in the vessel to hold the vessel open.
- The advancement of the stent through a patient's vasculature can involve traversing sharp bends and other obstacles which may require the stent to be highly flexible and trackable.
-
WO 02/091958 Al - The technical problem of the invention is to provide an intraluminal medical device having a crimped state in which the intraluminal medical device is securely crimped on a delivery device.
- The problem is solved by an intraluminal medical device according to claim 1.
- The intraluminal medical device has a pre-crimped diameter and a crimped diameter and is constructed and arranged such that the cylindrical shaped segments are crimped from the pre-crimped diameter to the crimped diameter and at least some of the end portions project inward. The inward projecting portions provide an improved retention on the balloon for delivery and deployment within the vasculature of a patient, while maintaining radial strength in the expanded configuration.
- The present invention provides a tubular, flexible, expandable intraluminal device generally referred to as a stent which has improved retention on the surface of a dilatation member, while maintaining radial strength in an expanded condition to maintain the patency of a body lumen such as an artery when implanted therein.
- In one embodiment, the present invention relates to an intraluminal medical device having a flowpath therethrough. The device includes a plurality of substantially cylindrical serpentine shaped segments which define a generally tubular body, each serpentine segment having a plurality of interconnected struts interconnected by alternating first and second end portions, the segments which are adjacent one another connected one to the other. Further, the medical device has a pre-crimped diameter and crimped diameter and is constructed and arranged such that as the cylindrical shaped segments are crimped from the pre-crimped diameter to the crimped diameter at least some of the end portions project into the delivery device. The projection of the end portions inwardly provides for improved securement to the delivery device prior to deployment at the desired location in the patient.
- The interconnected struts may be parallel or non-parallel.
- In some embodiments, the end portions are substantially elliptical and the struts are substantially parallel forming substantially u-shaped members.
- In some embodiments, the serpentine segments may be connected by connecting members of any configuration including curved, bent, linear, curvilinear, straight and so forth. In one particular embodiment, the connecting members are straight.
- The present invention further relates to the intraluminal medical devices in combination with a catheter assembly which may further include an inflation member.
-
-
Fig. 1 is a partial flat view of a stent according to the present invention in an unexpanded state. -
Fig. 2 illustrates a pair of parallel struts connected by an end portion in a pre-crimped state. -
Fig. 3 illustrates the same pair of struts as shown inFig. 2 in a crimped state. -
Fig. 4 illustrates the same pair of struts as shown inFigs. 2 and 3 in an expanded state. -
Fig. 5 a shows a three-dimensional view of one embodiment of a tubular stent in a precrimped state. -
Fig. 5b is a representation of the precrimped diameter of the tubular stent ofFig. 5a taken atsection 5b. -
Fig. 5c shows the same stent asFig. 5a in a crimped state. -
Fig. 5d is a representation of the crimped diameter of the tubular stent ofFig. 5c taken atsection 5d. -
Fig. 6a is a schematic representation of a tubular stent according to the present invention illustrating a pre-crimped diameter. -
Fig. 6b is a schematic representation of a tubular stent according to the present invention illustrating a crimped diameter relative to the pre-crimped diameter as illustrated inFig. 6a . -
Fig. 7a is a partial flat view of an embodiment of a stent of the present invention in a pre-crimped state. -
Fig. 7b shows a three-dimensional view of the tubular stent shown inFig. 8 a. -
Fig. 7c illustrates the same stent as shown inFigs. 7a and 7b in a crimped state. -
Fig. 7d shows a partial flat view of the stent ofFigs. 7a-7c in a pre-crimped state. -
Fig. 8a shows a partial flat view of an embodiment of the stent of the present invention in a pre-crimped state. -
Fig. 8b shows a three-dimensional view of an alternative embodiment of the tubular stent of the present invention having the stent pattern ofFig. 8a . -
Fig. 8c shows a three-dimensional view of the same stent shown inFigs. 8a and 8b in a crimped state. -
Fig. 9 shows a stent in a crimped state mounted on a dilatation member. -
Fig. 10 shows a stent mounted on the distal end of a catheter delivery device. - While this invention may be embodied in many different forms, there are described in detail herein specific embodiments of the invention. This description is an exemplification of the principles of the invention and is not intended to limit the invention to the particular embodiments illustrated.
- The radially expandable stents of the present invention are designed for relative flexibility along the longitudinal axis of the stent to facilitate delivery through tortuous body lumens, but exhibit radial strength in an expanded state to maintain the patency of a body lumen such as an artery when implanted therein.
- The radially expandable stents of the present invention may have a first pre-crimped or manufactured diameter, a second crimped diameter, and a third expanded diameter wherein the third diameter desirably exceeds the first diameter.
- In some embodiments, the present invention is directed to mechanically expandable stents formed with a pattern as described below, such pattern which is adapted for radial expansion from a first unexpanded or pre-crimped diameter to a second crimped diameter, and then to a third expanded diameter which approximates the inner diameter of the body lumen into which the stent is intended for implantation. The first pre-crimped diameter and third expanded diameter may or may not be similar. As noted above, the stents also have a second diameter referred to generally herein as the crimped diameter. The stents of the present invention desirably have a first unexpanded or pre-crimped diameter which is significantly larger than the second crimped diameter. The pre-crimped diameter may be substantially the same as the tubing size from which the stent is cut. Thus, the pre-crimped diameter may also be referred to as the diameter of the tubing as manufactured.
- One method of expanding a mechanically expandable stent is through the use of an inflation member, such as a dilatation balloon.
- The stents may be further designed so as to have flexible portions which deform during bending and portions which provide improved radiopacity and radial strength which remain largely undeformed during bending.
- Turning now to the figures,
Fig. 1 shows a fragmentary flat view of one embodiment of an unexpanded stent according to the present invention exhibiting a plurality ofadjacent segments 19, each of which is formed in an undulating flexible pattern of non-parallel struts 16. The struts may also be parallel. Pairs of struts are interconnected at alternatingend portions Fig. 1 , the interconnectingend portions 18b of one segment are positioned opposite interconnectingend portions 18a of adjacent segments. The end portions shown are generally elliptical resulting in substantially U-shaped members formed by adjacent non-parallel struts. However, such end portions may be rounded, squared, pointed, and so forth. Any configuration of the end portions is acceptable providing that it results in a serpentine or undulating pattern. - The stents of the present invention, in general, may be described as tubular, radially expandable structures which include a plurality of cylindrical shaped
open segments 19 aligned on a common longitudinal axis to define a generally tubular stent body. Eachsegment 19 may be defined by a member formed in an undulating flexible pattern ofinterconnected struts 16 with pairs thereof having alternating interconnectingend portions expandable stent segment 19. Theconnected end portions segment 19, before the stent is expanded, are optionally positioned substantially opposite toconnected end portions adjacent segments 19 and are 180° out of phase with one another. In other embodiments, they may be in phase with one another or may have any other phase relationship. - The
segments 19 are interconnected by a plurality of interconnectingelements 20 extending from some of theconnected end portions segment 19 to some of theconnected end portions adjacent segments 19. In the particular embodiment shown inFig. 1 , the connectingelements 20 extend angularly from connectingend portion end portion adjacent segment 19, not to an opposite connectingend portion adjacent segment 19, whereby upon expansion of thestent 10 theadjacent segments 19 are displaced relative to each other about the periphery of the stent body to accommodate flexing of thestent 10 within paired struts 16 without interference betweenadjacent segments 19. However, it is important to note that while the connecting elements in this particular embodiment are angular, the connectors may be straight, curvilinear, curved and so forth including s-shaped connectors, u-shaped connectors, v-shaped connectors, and so forth. The present invention is not intended to be limited to any particular type of connector and flexing may occur in the connectors, in the segment or both. - In the particular embodiment shown in
Fig. 2 , thestruts 16 and substantiallyelliptical end portions 18 form what may be referred to as a substantially U-shaped member shown in its pre-crimped state inFig. 2 . Of course, depending on the shape of theend portions - The U-shaped member of
Fig. 2 , for example, is shown in its crimped state inFig. 3 . Theend portions 18 are shown projecting inwardly according to the present invention. Without being bound by theory, the result of the projection of the end portions inwardly during crimping provides enhanced securement of the stent to an inflation member on a catheter delivery device for example, and also may result in improved tracking of the device through the vasculature. - The U-shaped member is further shown in an expanded state in
Fig. 4 . The ends 19 are shown having little projection either inwardly or outwardly in the expanded state. - Suitably, the
struts 16 of the intraluminal devices of the present invention have a strut width W which is not less than the strut thickness T shown inFigs. 2-4 . -
Fig. 5a illustrates generally at 10, a tubular, expandable stent of the present invention in its pre-crimped state. The diameter D1 of the stent in its pre-crimped state is taken at the proximal end of the stent and is noted assection 5b and is shown inFig. 5b . The diameter of the stent in the pre-crimped state is substantially equal to the diameter of the tubing from which the stent is cut and may typically be in the range of about 0.04" (about 1.0 mm) to as high as about 0.4" (about 10 mm) or higher. The range of tubing size employed may vary depending on the intended use of the stent.Fig. 5c shows the stent ofFig. 5a in a crimped state. The stent in its crimped stated has a diameter D2. The stent is typically crimped to a diameter of about 0.025" (about 0.6 mm) to about 0.08" (about 2 mm), and more typically about 0.04" (about 1 mm) to about 0.05" (about 1.3 nun). Again, this size may be dictated by the intended use of the stent. The diameter D2 of the stent in the crimped state is shown inFig. 5d . - Typically, the diameter D1 of a stent in the pre-crimped state is similar to the diameter D2 of the stent in the crimped state in contrast to the present invention in which the diameter D1 of the stent in the pre-crimped state is significantly larger than the diameter D2 of the stent in the crimped state.
Fig. 6a and 6b , expanded views, illustrate an embodiment of the invention in which the stent is crimped from a pre-crimped diameter D1 to a crimped diameter D2. The pre-crimped diameter D1 is approximately four times that of the crimped diameter D2. - In an expanded state, a stent may range from about 2 mm to about 30 mm (about 0.08" to about 1.2").
-
Fig. 7a shows a partial flat view of an alternative embodiment of a stent of the present invention in a pre-crimped state in whichconnectors 20, rather than being angular as shown in one embodiment above, are curved. The curvature ofsuch connectors 20 may be varied.Connectors 20 are also shown between everyadjacent end portion Fig. 1 , for example, there arefewer connectors 20 between pairs ofstruts 16 with oneconnector 20 for every three pairs ofstruts 16. - The strut pairs, shown as being substantially parallel, are joined by
elliptical end portions Fig. 1 forming substantially u-shaped members. -
Fig. 7b illustrates the same stent as shown inFig. 7a but in the tubular form. The stent may be formed by etching the pattern in a flat sheet and then rolling the sheet and sealing the edges together such as by welding in the case of a metal, or the stent pattern may be cut from a hollow tubular member. The stent may be formed from multiple sheets or multiple tubular members, as well as from multiple materials. As used herein, the term "multiple" shall be used to refer to two or more. -
Fig. 7c illustrates the same stent as shown inFigs. 7a and 7b in a crimped state. Theend portions Fig. 7c . The diameter of the stent in a pre-crimped state is significantly larger than the diameter of the stent in the crimped state.Figs. 7b and7c are not shown dimensionally accurate to one another. -
Fig. 7d shows a partial flat view of the stent in an expanded state. In the expanded state, theend portions -
Fig. 8a shows a partial flat view of an alternative embodiment of a stent of the present invention in a pre-crimped state in whichconnectors 20 are straight. -
Fig. 8b shows a three dimensional view of the stent ofFig. 8a in its tubular form. In this embodiment, a firstserpentine portion 12 eight peaks and eight troughs also referred to herein asend portions connectors 20 per serpentine band. Every second peak has aconnector 20 extending therefrom. A secondserpentine portion 14 has twelve peaks and twelve troughs per serpentine portion also referred to herein asend portions connector 20 extending therefrom. The ratio of end portions in the first serpentine band to end portions in the second serpentine band is thus 2:3.End portions adjacent struts 16a of the firstserpentine portions 12.Struts 16a are longer thanstruts 16b of the secondserpentine portions 14 which are also connected by elliptical shapedend portions - In this embodiment as well as the other embodiments disclosed herein, the stent may be formed by laser cutting a tube of stainless steel, or any other suitable stent material, and polished to smooth and round the edge surfaces. However, such a pattern may also be cut from a single flat sheet of metal such as stainless steel, and then rolling the sheet and sealing the edges together such as by welding in the case of a metal, or the stent pattern may be cut from a hollow tubular member. Furthermore, the stent may be formed from more than one flat sheet or from one tubular member. The stent may be formed using multiple materials as well.
-
Fig. 8c illustrates the same stent as shown inFigs. 8a and 8b in a crimped state. At least some of the end portions, 18a, 18b, 18c, 18d of the u-shaped members project inwardly as shown inFig. 8c . The stent has firstserpentine portions 12 which havestruts 16a longer thanstruts 16b of secondserpentine portions 14. Theend portions serpentine portions 12 are shown projecting inwardly. Theend portions serpentine portions 14 are shown in this embodiment as not projecting inwardly. However, in an alternate embodiment,end portions serpentine portions 14 could also project inwardly. - The diameter of the stent shown in
Fig. 8a-8c in a pre-crimped state is larger than the diameter of the stent in the crimped state. It is important to note that the stents, and thus the diameters, are not drawn to scale. The diameter should be reduced by a factor of at least about 2 from the pre-crimped state to the crimped state.Figs. 8b and8c are not shown dimensionally accurate to one another and thus are not representative of the relative diameters of the stent as shown inFig. 8b to that same stent in crimped form shown inFig. 8c . -
Fig. 10 shows the same stent as inFig. 8c in its crimped state and mounted on adilatation member 40. - Other suitable stent patterns for use in the present invention are found, for example, in
US 5733303 . - The stents of the present invention may be manufactured from any materials known in the art for use in forming such members, and suitably the tubular members may be made of a biocompatible material. Examples include, but are not limited to, the shape memory materials, noble metals, transition metals, any alloys of the shape memory materials, noble metals, transition metals, polymeric materials, and so forth.
- Suitably, the stent may be manufactured of stainless steel alloys which include, but are not limited to, Special Chemistry of type 316L SS per ASTM F138-92 or ASTM F139-92
grade 2 and Special Chemistry of type 316L per ASTM F138-92 or ASTM F139-92 and so forth. - Other metals suitable for formation of the inventive stents of the present invention include, but are not limited to the more radiopaque metals including the noble metals gold and platinum, and tantalum; iridium, palladium, tungsten, titanium, chromium, cobalt, molybdenum, nickel, silver, copper, zinc, and so forth, and alloys thereof.
- Specific examples of alloys useful for manufacture of the inventive stents herein include, but are not limited to, nickel-titanium, cobalt-chromium, cobalt-chromium-molybdenum, and so forth.
- The above materials are known to those of skill in the art and those listed are intended for exemplary purposes only. This list is by no means exhaustive of the types of materials which may be employed in the manufacture of the stents of the present invention.
- The stent may be formed according to any method known in the art including etching a pattern and then rolling the sheet and sealing the edges together such as by welding, for example, or the stent may be cut from a hollow tube. If a flat metal sheet is employed, the etched pattern is then rolled into a tube and the tube is optionally welded or the like.
- The stents of the present invention in combination with the inflation members may be further mounted on the distal end of a stent delivery catheter which is then passed through the body lumen to the site of implantation. The stent is mounted on the balloon catheter by crimping it onto the catheter employing methods known in the art.
Fig. 9 illustrates astent 10 of the present invention shown crimped to a dilatation member, in this embodiment, acatheter balloon 40 of a delivery catheter shown generally at 50. - The catheter delivery device shown in
Fig. 10 is intended for illustrative purposes only. Catheter delivery devices useful for delivery of a medical device of the type described herein are well known to those of ordinary skill in the art and as such any suitable delivery catheter may be employed herein. - The stent and the inflation member are typically compressed or crimped onto the catheter structure for delivery to the implantation site where the inflation member is inflated typically with an inflation fluid thus expanding the stent. Crimping devices are well known in the art and any suitable crimping device may be employed. The inflation member is then deflated and the catheter assembly removed from the body lumen leaving the stent behind.
- The above disclosure is intended for illustrative purposes only and is not exhaustive. The embodiments described therein will suggest many variations and alternatives to one of ordinary skill in this art. All these alternatives and variations are intended to be included within the scope of the attached claims. Those familiar with the art may recognize other equivalents to the specific embodiments described herein which equivalents are also intended to be encompassed by the claims attached hereto.
Claims (26)
- An intraluminal medical device having a pre-crimped state, a crimped state, and an expanded state, and having a flowpath therethrough, the device comprising:• a plurality of substantially cylindrical serpentine shaped segments (19) which define a generally tubular body, each serpentine segment having a plurality of struts (16) interconnected by alternating end portions (18a, 18b), segments which are adjacent one another connected one to the other ;• the medical device having a pre-crimped diameter and crimped diameter and constructed and arranged such that as the cylindrical shaped segments are crimped from the pre-crimped diameter to the crimped diameter at least some of the end portions project inward.
- The intraluminal medical device of Claim 1 wherein said intraluminal medical device is a stent.
- The intraluminal medical device of Claim 1 comprising a plurality of connecting members, each connecting member connecting cylindrical shaped segments which are adjacent one another.
- The intraluminal device of Claim 1 wherein the medical device is constructed and arranged such that as the cylindrical shaped segments are crimped from the precrimped diameter to the crimped diameter at least some of the end portions project inward.
- The intraluminal device of Claim 1 wherein the medical device is constructed and arranged such that as the cylindrical shaped segments are crimped from the precrimped diameter to the crimped diameter more than half of the end portions project inward.
- The intraluminal device of Claim 1 wherein the medical-device is constructed and arranged such that as the cylindrical shaped segments are crimped from the precrimped diameter to the crimped diameter all of the end portions project inward.
- The intraluminal medical device of Claim 1 wherein the pre-crimped diameter is about two times the crimped diameter or greater.
- The intraluminal medical device of Claim 1 wherein the pre-crimped diameter is about four times the crimped diameter or greater.
- The intraluminal medical device of Claim 1 wherein the pre-crimped diameter of the stent is about 2,5 mm (0. 1") or greater.
- The intraluminal medical device of Claim 1 wherein the pre-crimped diameter of the stent is about 3.8 mm (0. 15") or greater.
- The intraluminal medical device of Claim 1 wherein the pre-crimped diameter of the stent is about 1.3 mm (0. 05") to about 8.9 mm (0.35").
- The intraluminal medical device of Claim 1 wherein the pre-crimped diameter of the stent is about 2.5 mm (0. 1 ") to about 6.4 mm (0.25").
- The intraluminal medical device of Claim 1 wherein the crimped diameter of the stent is about 0.6 mm (0. 025") to about 2.0 mm (0.08").
- The intraluminal medical device of Claim 1 wherein the crimped diameter of the stent is about 1 mm (0. 04") to about 1.3 mm (0.05").
- The intraluminal medical device of Claim 1 wherein the stent is comprised of at least one metal, at least one plastic or composites thereof.
- The intraluminal medical device of Claim 15 wherein the metal is stainless steel.
- The intraluminal medical device of Claim 1 wherein said intraluminal medical device is mechanically expandable.
- The intraluminal medical device of Claim 1 wherein the stent is a thin-walled tubular member.
- The intraluminal medical device of Claim 1 in combination with a catheter delivery device, the stent disposed about a portion of the catheter delivery device.
- The intraluminal medical device of Claim 19 further including an inflation member.
- The intraluminal medical device of Claim 20 wherein said inflation member is a dilatation balloon.
- The intraluminal medical device of Claim 1 wherein the serpentine shaped segments are comprised of a plurality of interconnected struts, the struts having a minimum width equal to or greater than a maximum strut thickness.
- The intraluminal medical device of Claim 1 wherein adjacent pairs of struts are substantially parallel in the pre-crimped state and are connected by substantially elliptical end portions forming substantially U-shaped members.
- The intraluminal medical device of Claim 23 wherein said end portions of said substantially U-shaped members have a substantially uniform radius of curvature.
- The intraluminal medical device of Claim 23 wherein at least some of the end portions of the substantially U-shaped members deform when the intraluminal medical device is crimped from its pre-crimped diameter to its crimped diameter, the deformed end portions projecting radially inwardly as the intraluminal medical device is crimped to the smaller crimped diameter.
- The intraluminal medical device of Claim 1 wherein said end portions exhibit substantially no inward projection in a pre-crimped state.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US306518 | 2002-11-27 | ||
US10/306,518 US6997946B2 (en) | 2002-11-27 | 2002-11-27 | Expandable stents |
PCT/US2003/036270 WO2004049972A2 (en) | 2002-11-27 | 2003-11-13 | Expandable stents |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1565129A2 EP1565129A2 (en) | 2005-08-24 |
EP1565129B1 true EP1565129B1 (en) | 2012-03-07 |
Family
ID=32325710
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP03812435A Expired - Lifetime EP1565129B1 (en) | 2002-11-27 | 2003-11-13 | Expandable stents |
Country Status (6)
Country | Link |
---|---|
US (1) | US6997946B2 (en) |
EP (1) | EP1565129B1 (en) |
AT (1) | ATE548003T1 (en) |
AU (1) | AU2003302601A1 (en) |
ES (1) | ES2380931T3 (en) |
WO (1) | WO2004049972A2 (en) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8382821B2 (en) | 1998-12-03 | 2013-02-26 | Medinol Ltd. | Helical hybrid stent |
AU2002320456A1 (en) * | 2001-07-26 | 2003-02-17 | Alveolus Inc. | Removable stent and method of using the same |
EP1549254A4 (en) * | 2002-09-27 | 2007-11-07 | Medlogics Device Corp | Implantable stent with modified ends |
US9039755B2 (en) | 2003-06-27 | 2015-05-26 | Medinol Ltd. | Helical hybrid stent |
US9155639B2 (en) | 2009-04-22 | 2015-10-13 | Medinol Ltd. | Helical hybrid stent |
US8012192B2 (en) * | 2004-02-18 | 2011-09-06 | Boston Scientific Scimed, Inc. | Multi-stent delivery system |
US20140107761A1 (en) | 2004-07-26 | 2014-04-17 | Abbott Cardiovascular Systems Inc. | Biodegradable stent with enhanced fracture toughness |
US7971333B2 (en) | 2006-05-30 | 2011-07-05 | Advanced Cardiovascular Systems, Inc. | Manufacturing process for polymetric stents |
US8747879B2 (en) | 2006-04-28 | 2014-06-10 | Advanced Cardiovascular Systems, Inc. | Method of fabricating an implantable medical device to reduce chance of late inflammatory response |
US7731890B2 (en) | 2006-06-15 | 2010-06-08 | Advanced Cardiovascular Systems, Inc. | Methods of fabricating stents with enhanced fracture toughness |
EP1827307B1 (en) * | 2004-12-09 | 2010-05-05 | Med Institute, Inc. | Variable curvature stent |
US9107899B2 (en) | 2005-03-03 | 2015-08-18 | Icon Medical Corporation | Metal alloys for medical devices |
US7540995B2 (en) | 2005-03-03 | 2009-06-02 | Icon Medical Corp. | Process for forming an improved metal alloy stent |
DE102005019649A1 (en) * | 2005-04-26 | 2006-11-02 | Alveolus Inc. | Flexible stent for positioning in lumen of esophagus comprises tube and stabilization members defined circumferentially about tube, where each member extends inwardly in tube to define inner diameter that is less than inner diameter of tube |
US8961586B2 (en) | 2005-05-24 | 2015-02-24 | Inspiremd Ltd. | Bifurcated stent assemblies |
WO2006126182A2 (en) | 2005-05-24 | 2006-11-30 | Inspire M.D Ltd. | Stent apparatuses for treatment via body lumens and methods of use |
US8043323B2 (en) | 2006-10-18 | 2011-10-25 | Inspiremd Ltd. | In vivo filter assembly |
US20070173925A1 (en) * | 2006-01-25 | 2007-07-26 | Cornova, Inc. | Flexible expandable stent |
US20070282433A1 (en) * | 2006-06-01 | 2007-12-06 | Limon Timothy A | Stent with retention protrusions formed during crimping |
US20070281071A1 (en) * | 2006-06-06 | 2007-12-06 | Boston Scientific Scimed, Inc. | Acoustically coating workpieces |
WO2008008291A2 (en) * | 2006-07-13 | 2008-01-17 | Icon Medical Corp. | Stent |
US9173733B1 (en) | 2006-08-21 | 2015-11-03 | Abbott Cardiovascular Systems Inc. | Tracheobronchial implantable medical device and methods of use |
US20080215132A1 (en) * | 2006-08-28 | 2008-09-04 | Cornova, Inc. | Implantable devices having textured surfaces and methods of forming the same |
CA2666728C (en) | 2006-10-18 | 2015-06-23 | Asher Holzer | Knitted stent jackets |
EP3292837B1 (en) | 2006-11-22 | 2022-11-09 | Inspire M.D Ltd | Optimized stent jacket |
US8974514B2 (en) * | 2007-03-13 | 2015-03-10 | Abbott Cardiovascular Systems Inc. | Intravascular stent with integrated link and ring strut |
US20080269746A1 (en) * | 2007-04-24 | 2008-10-30 | Osteolign, Inc. | Conformable intramedullary implant with nestable components |
WO2009033058A1 (en) * | 2007-09-06 | 2009-03-12 | Cook Incorporated | Stent, stent graft and other implantable assemblies |
US20090093869A1 (en) * | 2007-10-04 | 2009-04-09 | Brendan Cunniffe | Medical device with curved struts |
US20090105806A1 (en) * | 2007-10-23 | 2009-04-23 | Endologix, Inc | Stent |
US8291781B2 (en) | 2007-12-21 | 2012-10-23 | Schlumberger Technology Corporation | System and methods for actuating reversibly expandable structures |
US8398916B2 (en) | 2010-03-04 | 2013-03-19 | Icon Medical Corp. | Method for forming a tubular medical device |
US20130079866A1 (en) * | 2011-09-23 | 2013-03-28 | Nathaniel A. Irwin | Stent geometry |
EP2822504B1 (en) * | 2012-03-07 | 2018-05-16 | OrbusNeich Medical, Inc. | Medical device for implantation into luminal structures |
KR101498584B1 (en) * | 2013-05-15 | 2015-03-04 | 주식회사 스텐다드싸이텍 | Stent to prevent migration |
CN106535826A (en) | 2014-06-24 | 2017-03-22 | 怡康医疗股份有限公司 | Improved metal alloys for medical devices |
WO2016054193A1 (en) | 2014-09-30 | 2016-04-07 | Boston Scientific Scimed, Inc. | Dual-layer balloon design and method of making the same |
US11766506B2 (en) | 2016-03-04 | 2023-09-26 | Mirus Llc | Stent device for spinal fusion |
US10849769B2 (en) | 2017-08-23 | 2020-12-01 | Vesper Medical, Inc. | Non-foreshortening stent |
CN108938161B (en) * | 2017-11-17 | 2021-07-06 | 杭州唯强医疗科技有限公司 | Peripheral vascular stent |
CN108836566A (en) * | 2018-04-23 | 2018-11-20 | 北京大学 | A kind of New-support improving dog bone effect |
US10932927B2 (en) | 2018-08-29 | 2021-03-02 | DePuy Synthes Products, Inc. | Stent with longitudinal variable width struts |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4950227A (en) | 1988-11-07 | 1990-08-21 | Boston Scientific Corporation | Stent delivery system |
US5156785A (en) | 1991-07-10 | 1992-10-20 | Cordis Corporation | Extruded tubing and catheters having increased rotational stiffness |
US5344426A (en) | 1990-04-25 | 1994-09-06 | Advanced Cardiovascular Systems, Inc. | Method and system for stent delivery |
US5158548A (en) | 1990-04-25 | 1992-10-27 | Advanced Cardiovascular Systems, Inc. | Method and system for stent delivery |
CA2060067A1 (en) | 1991-01-28 | 1992-07-29 | Lilip Lau | Stent delivery system |
CA2079417C (en) | 1991-10-28 | 2003-01-07 | Lilip Lau | Expandable stents and method of making same |
US5437083A (en) | 1993-05-24 | 1995-08-01 | Advanced Cardiovascular Systems, Inc. | Stent-loading mechanism |
US5733303A (en) | 1994-03-17 | 1998-03-31 | Medinol Ltd. | Flexible expandable stent |
US6436444B1 (en) | 1997-09-26 | 2002-08-20 | Ecolab Inc. | Acidic aqueous chlorite teat dip providing shelf life sanitizing capacity and tissue protection |
US6325824B2 (en) * | 1998-07-22 | 2001-12-04 | Advanced Cardiovascular Systems, Inc. | Crush resistant stent |
US6312459B1 (en) * | 1999-06-30 | 2001-11-06 | Advanced Cardiovascular Systems, Inc. | Stent design for use in small vessels |
US6565597B1 (en) | 1999-07-16 | 2003-05-20 | Med Institute, Inc. | Stent adapted for tangle-free deployment |
US6579310B1 (en) | 2000-08-17 | 2003-06-17 | Advanced Cardiovascular Systems, Inc. | Stent having overlapping struts |
CN1255084C (en) | 2001-02-09 | 2006-05-10 | 奥勃斯医学技术股份有限公司 | Crimpable intraluminal endoprosthesis having helical elements |
US7060089B2 (en) | 2002-01-23 | 2006-06-13 | Boston Scientific Scimed, Inc. | Multi-layer stent |
-
2002
- 2002-11-27 US US10/306,518 patent/US6997946B2/en not_active Expired - Lifetime
-
2003
- 2003-11-13 EP EP03812435A patent/EP1565129B1/en not_active Expired - Lifetime
- 2003-11-13 AT AT03812435T patent/ATE548003T1/en active
- 2003-11-13 WO PCT/US2003/036270 patent/WO2004049972A2/en not_active Application Discontinuation
- 2003-11-13 AU AU2003302601A patent/AU2003302601A1/en not_active Abandoned
- 2003-11-13 ES ES03812435T patent/ES2380931T3/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
WO2004049972A2 (en) | 2004-06-17 |
WO2004049972A3 (en) | 2004-09-16 |
US6997946B2 (en) | 2006-02-14 |
AU2003302601A8 (en) | 2004-06-23 |
EP1565129A2 (en) | 2005-08-24 |
ES2380931T3 (en) | 2012-05-21 |
US20040102833A1 (en) | 2004-05-27 |
ATE548003T1 (en) | 2012-03-15 |
AU2003302601A1 (en) | 2004-06-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1565129B1 (en) | Expandable stents | |
US8016878B2 (en) | Bifurcation stent pattern | |
US6331189B1 (en) | Flexible medical stent | |
EP2059199B1 (en) | Longitudinally flexible expandable stent | |
EP1954223B1 (en) | Stent configurations | |
US7842081B2 (en) | Stent with spiral side-branch | |
US9427340B2 (en) | Stent with protruding branch portion for bifurcated vessels | |
US6913619B2 (en) | Longitudinally flexible expandable stent | |
US6918928B2 (en) | Medical device for intraluminal endovascular stenting | |
JP4278874B2 (en) | Stent having struts with different geometric shapes | |
USRE44763E1 (en) | Expandable unit cell and intraluminal stent | |
EP1208814B1 (en) | Low profile stent | |
CA2144305C (en) | A flexible stent having a pattern formed from a sheet of material | |
US8317855B2 (en) | Crimpable and expandable side branch cell | |
US5899934A (en) | Dual stent | |
US7988720B2 (en) | Longitudinally flexible expandable stent | |
US20070260304A1 (en) | Bifurcated stent with minimally circumferentially projected side branch | |
WO2007102974A1 (en) | Bifurcation stent with uniform side branch projection | |
US20090149945A1 (en) | Prosthetic support for flaccid arterial segments |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20050615 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK |
|
DAX | Request for extension of the european patent (deleted) | ||
17Q | First examination report despatched |
Effective date: 20081007 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R079 Ref document number: 60340234 Country of ref document: DE Free format text: PREVIOUS MAIN CLASS: A61F0002060000 Ipc: A61F0002900000 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61F 2/90 20060101AFI20110819BHEP |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 548003 Country of ref document: AT Kind code of ref document: T Effective date: 20120315 Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: T3 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 60340234 Country of ref document: DE Effective date: 20120503 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2380931 Country of ref document: ES Kind code of ref document: T3 Effective date: 20120521 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120307 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120608 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 548003 Country of ref document: AT Kind code of ref document: T Effective date: 20120307 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120307 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120307 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120307 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120307 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120307 Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120307 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120307 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120307 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120709 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120307 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120307 |
|
26N | No opposition filed |
Effective date: 20121210 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 60340234 Country of ref document: DE Effective date: 20121210 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120607 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20121130 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20121130 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20121113 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20131108 Year of fee payment: 11 Ref country code: IE Payment date: 20131112 Year of fee payment: 11 Ref country code: GB Payment date: 20131113 Year of fee payment: 11 Ref country code: DE Payment date: 20131106 Year of fee payment: 11 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 20131109 Year of fee payment: 11 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20140305 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120307 Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20121130 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20121113 Ref country code: ES Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20121114 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: CA Effective date: 20140513 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20031113 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R082 Ref document number: 60340234 Country of ref document: DE Representative=s name: KANZLEI PFENNING, MEINIG & PARTNER GBR, DE |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R082 Ref document number: 60340234 Country of ref document: DE Representative=s name: KANZLEI PFENNING, MEINIG & PARTNER GBR, DE |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R081 Ref document number: 60340234 Country of ref document: DE Owner name: BOSTON SCIENTIFIC LIMITED, BM Free format text: FORMER OWNER: BOSTON SCIENTIFIC LTD., ST. MICHAEL, BARBADOS, BB Effective date: 20120308 Ref country code: DE Ref legal event code: R082 Ref document number: 60340234 Country of ref document: DE Representative=s name: KANZLEI PFENNING, MEINIG & PARTNER GBR, DE Effective date: 20140930 Ref country code: DE Ref legal event code: R081 Ref document number: 60340234 Country of ref document: DE Owner name: BOSTON SCIENTIFIC LIMITED, BM Free format text: FORMER OWNER: BOSTON SCIENTIFIC LTD., ST. MICHAEL, BARBADOS, BB Effective date: 20150203 Ref country code: DE Ref legal event code: R082 Ref document number: 60340234 Country of ref document: DE Representative=s name: KANZLEI PFENNING, MEINIG & PARTNER GBR, DE Effective date: 20150203 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 60340234 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: V1 Effective date: 20150601 |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20141113 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST Effective date: 20150731 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20150601 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20141113 Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20150602 Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20141113 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20141201 |